de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
In today’s fast-paced world, many people struggle with getting a good night’s sleep. Insomnia and sleep disorders are becoming increasingly common, leading to a host of health issues. While there are ...
Information from the National Institutes of Health (NIH) confirms that results from several clinical trials suggest ashwagandha may be effective for reducing stress and anxiety.
It is considered an older-generation antidepressant. It was FDA-approved for treating anxiety and depression in 1981. Trazodone isn't a sleep medicine, but it has sedative or hypnotic effects, meaning ...
More than a third of respondents (41%) reported dissatisfaction with the effectiveness of their current or more recent antidepressant in treating their insomnia. Among respondents reporting severe ...